ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,700.79
      1.40%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kazia Therapeutics Ltd (KZIA)

      7. Kazia Therapeutics Ltd (KZIA) News

      KZIA

      Kazia Therapeutics (KZIA)

      Kazia Therapeutics Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KZIA
      DateTimeSourceHeadlineSymbolCompany
      10/30/20087:18PMMarketwiredMarshall Edwards' Phenoxodiol and Novogen's NV-128 Display Divergent Mechanisms of Action but Potent Synergistic Anti-Cancer ActNASDAQ:KZIAKazia Therapeutics Ltd
      10/29/20086:59AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      10/22/20086:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      10/22/20086:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      08/29/20086:03AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      08/12/20086:01AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      08/11/20088:15AMMarketwiredMarshall Edwards, Inc. to Present at the Canaccord Adams 28th Annual Global Growth ConferenceNASDAQ:KZIAKazia Therapeutics Ltd
      08/08/20083:24PMEdgar (US Regulatory)Novogen Ltd - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:KZIAKazia Therapeutics Ltd
      08/04/20087:14AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      07/31/20083:24PMEdgar (US Regulatory)Novogen Ltd - Statement of Changes in Beneficial Ownership (4)NASDAQ:KZIAKazia Therapeutics Ltd
      07/30/20088:27AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      07/30/20088:25AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      07/30/20088:21AMMarketwiredNovogen Raises A$5.5m for Investment in Marshall EdwardsNASDAQ:KZIAKazia Therapeutics Ltd
      07/30/20088:15AMMarketwiredMarshall Edwards, Inc. Raises $10,000,000 in Public OfferingNASDAQ:KZIAKazia Therapeutics Ltd
      06/27/20086:02AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      06/26/20088:08AMMarketwiredMarshall Edwards, Inc. Joins Russell 3000(R) IndexNASDAQ:KZIAKazia Therapeutics Ltd
      06/23/20088:02AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      06/23/20088:00AMMarketwiredNovogen Signs Spanish Patent License With Laboratorios Casen-FleetNASDAQ:KZIAKazia Therapeutics Ltd
      06/09/20088:06AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      06/09/20088:00AMMarketwiredIndependent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial ContinueNASDAQ:KZIAKazia Therapeutics Ltd
      05/16/20088:42AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      05/15/20089:00PMMarketwiredClinical Phase I Study Report of Marshall Edwards' Compound Triphendiol to Be Reported in ASCO ProceedingsNASDAQ:KZIAKazia Therapeutics Ltd
      05/13/20086:02AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      05/09/20088:28AMMarketwiredExtended Accrual Time and Decreased Sample Size for OVATURE, a Multinational Phase III Clinical Study for Women With Recurrent ONASDAQ:KZIAKazia Therapeutics Ltd
      05/06/20086:02AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      04/15/20085:25PMMarketwiredNovogen's NV-128 Is a Unique Inhibitor of mTOR Dephosphorylation Leading to Caspase Independent Death in Chemoresistant Cancer CNASDAQ:KZIAKazia Therapeutics Ltd
      04/15/20086:02AMEdgar (US Regulatory)Novogen Ltd - Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      04/13/20084:00PMMarketwiredMarshall Edwards, Inc.'s Investigational Drug Triphendiol (NV-196) Demonstrates Potent Activity Against Biliary CancersNASDAQ:KZIAKazia Therapeutics Ltd
      04/02/20088:00AMMarketwiredNovogen Cardiovascular Drug Enters Phase I Clinical TrialNASDAQ:KZIAKazia Therapeutics Ltd
      03/27/20086:13PMEdgar (US Regulatory)Novogen Ltd - Statement of Changes in Beneficial Ownership (4)NASDAQ:KZIAKazia Therapeutics Ltd
       Showing the most relevant articles for your search:NASDAQ:KZIA